Xinglong Wang, PhD
Affiliations: | 2005-2020 | Pathology | Case Western Reserve University, Cleveland Heights, OH, United States |
| 2020-2022 | Pharmacology and Experimental Neuroscience | University of Nebraska Medical Center, Omaha, NE, United States | |
| 2022- | Pharmacology and Toxicology | University of Arizona, Tucson, AZ |
Area:
Alzheimer DiseaseWebsite:
http://en.scientificcommons.org/xinglong_wangGoogle:
"Xinglong Wang"Bio:
http://www.case.edu/medicus/magazine/winter2010/beautyofbiology.html
Cross-listing: Neurotree
Parents
Sign in to add mentor| George Perry | grad student | 2005-2009 | Case Western | |
| Xiongwei Zhu | grad student | 2005-2009 | Case Western | |
| (Impaired balance of mitochondria fission and fusion in Alzheimer disease.) | ||||
Children
Sign in to add trainee| Sirui Jiang | grad student | 2014- | Case Western (Neurotree) |
| Devanshi B Shukla | grad student | 2021- | University of Nebraska Medical Center (Neurotree) |
| Mengyu Liu | grad student | 2017-2019 | Case Western (Neurotree) |
| Wenzhang Wang | post-doc | 2011- | Case Western (Neurotree) |
| Li Zhang | post-doc | 2011- | Case Western (Neurotree) |
| Ju Gao | post-doc | 2015- | Case Western (Neurotree) |
| Luwen Wang | post-doc | 2015- | Case Western (Neurotree) |
| Fanqiang Tang | post-doc | 2013-2015 | Case Western (Neurotree) |
| Zheng Jiang | post-doc | 2015-2015 | Case Western (Neurotree) |
| Tingxiang Yan | post-doc | 2017-2019 | Case Western (Neurotree) |
| Xiaojia Ren | post-doc | 2020-2022 | University of Nebraska Medical Center (Neurotree) |
| Li Li | research scientist | 2012-2013 | Case Western (Neurotree) |
| Fan Zhang | research scientist | 2013-2014 | Case Western (Neurotree) |
| Pichet Termsarasab | research scientist | 2017-2018 | Case Western (Neurotree) |
Collaborators
Sign in to add collaborator| George Perry | collaborator | Case Western | |
| Mark Anthony Smith | collaborator | Case Western |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Leng L, Yuan Z, Pan R, et al. (2022) Microglial hexokinase 2 deficiency increases ATP generation through lipid metabolism leading to β-amyloid clearance. Nature Metabolism |
| Yan T, Liang J, Gao J, et al. (2022) Author Correction: FAM222A encodes a protein which accumulates in plaques in Alzheimer's disease. Nature Communications. 13: 4006 |
| Morsy A, Maddeboina K, Gao J, et al. (2022) Functionalized Allopurinols Targeting Amyloid-Binding Alcohol Dehydrogenase Rescue Aβ-Induced Mitochondrial Dysfunction. Acs Chemical Neuroscience |
| Machhi J, Yeapuri P, Markovic M, et al. (2022) Europium-Doped Cerium Oxide Nanoparticles for Microglial Amyloid Beta Clearance and Homeostasis. Acs Chemical Neuroscience |
| Machhi J, Yeapuri P, Lu Y, et al. (2021) CD4+ effector T cells accelerate Alzheimer's disease in mice. Journal of Neuroinflammation. 18: 272 |
| Wang L, Liu M, Gao J, et al. (2021) Mitochondrial Fusion Suppresses Tau Pathology-Induced Neurodegeneration and Cognitive Decline. Journal of Alzheimer's Disease : Jad |
| Gao J, Wang L, Ren X, et al. (2021) Translational regulation in the brain by TDP-43 phase separation. The Journal of Cell Biology. 220 |
| Termsarasab P, Thammongkolchai T, Gao J, et al. (2020) Cytoplasmic mislocalization and mitochondrial colocalization of TDP-43 are common features between normal aged and young mice. Experimental Biology and Medicine (Maywood, N.J.). 1535370220914253 |
| Yan T, Liang J, Gao J, et al. (2020) FAM222A encodes a protein which accumulates in plaques in Alzheimer's disease. Nature Communications. 11: 411 |
| Harland M, Torres S, Liu J, et al. (2020) Neuronal mitochondria modulation of LPS-induced neuroinflammation. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience |